Does Anavar Raise Blood Pressure? What the Research Shows

The anavar blood pressure connection is not fully mapped in supervised clinical research, so it helps to separate lipid effects from blood pressure itself. Oxandrolone's androgenic activity can lower HDL cholesterol, and LDL may rise.

That lipid shift is a long-term cardiovascular consideration in its own right, which is one reason providers may review lipid labs alongside blood pressure readings. Burn-care meta-analyses by Ring et al. (2020) in the Journal of Burn Care and Research and Lou et al. (2025) in the World Journal of Emergency Surgery reviewed oxandrolone under clinical supervision, but they focused on recovery outcomes and liver safety, not blood pressure or lipid changes.

How lipid changes fit in

Former oxandrolone labeling noted that oral androgens can lower HDL and raise LDL. The result can be a less favorable lipid ratio, a long-term cardiovascular risk factor that providers may follow with repeat lipid labs.

A direct causal link between these lipid changes and higher blood pressure has not been established, and the size of the shift during supervised short-term use varies by individual. Research involving populations who used anabolic steroids outside of medical supervision reports higher blood pressure among users, but those studies did not isolate anavar and cannot be applied directly to supervised clinical use.

Does Anavar affect systolic or diastolic pressure more?

In studies of anabolic steroid users, systolic pressure appears to be affected more than diastolic pressure, although the reason is not established. A study presented at the Endocrine Society's ENDO 2016 meeting by Rasmussen et al. associated anabolic steroid abuse with higher systolic blood pressure and more frequent nighttime systolic hypertension in men who used AAS without medical supervision, while diastolic pressure was similar across groups.

How that pattern applies to supervised, short-term clinical use is not firmly established in the literature. A licensed provider may ask for home or in-clinic readings to follow both systolic and diastolic pressure during treatment.

Does anavar raise blood pressure to a level that requires action? That depends on individual baseline health, treatment duration, and how closely the provider tracks cardiovascular variables. Monitoring typically starts before treatment and may continue throughout. For more on how providers individualize protocols based on labs and clinical history, see how providers determine oxandrolone protocols.

• Before treatment: A provider reviews cardiovascular history and a baseline lipid panel covering HDL and LDL, and may ask for a home or in-clinic blood pressure reading to establish the individual starting point.
• During treatment: Providers may request periodic blood pressure readings, at home or in clinic, and schedule follow-up lipid labs at intervals they determine based on individual response.
• Alert symptoms: contact your provider or seek emergency care if you notice chest pain, shortness of breath, or unusual swelling in the legs or ankles.

Understanding what your lab values mean in context, beyond what falls in a "normal" range, is covered in the guide to essential lab testing for peptides and hormones.

No clean clinical figure exists for supervised-use populations. Magnitude varies by individual. Available data on anavar and blood pressure come from studies of anabolic steroid users in general, not oxandrolone specifically, mostly outside of medical supervision at supraphysiological doses.

A small 1992 study by Riebe et al. of nine anabolic steroid users found higher resting and exercise blood pressure than in non-users, although adjusting for body weight or arm size removed the statistically significant differences. These users were neither under provider supervision nor representative of short-term clinical treatment.

The ENDO 2016 study by Rasmussen et al. found average day and night blood pressure roughly 8 to 10 mmHg higher in men currently using AAS without medical supervision than in former users and non-users. It did not isolate oxandrolone, so it is not direct anavar high blood pressure evidence, and that unsupervised context does not transfer to supervised clinical care.

Applying those figures to supervised treatment is not scientifically valid. Individual monitoring, not population averages, guides a provider's response.

Most published data on whether anavar causes high blood pressure come from unsupervised anabolic steroid misuse rather than clinical treatment. That context matters. Clinics and hospitals have used oxandrolone in burn recovery, as documented by burn-care meta-analyses from Ring et al. (2020) and Lou et al. (2025). These are controlled settings with provider oversight throughout.

Oxandrolone carries no current FDA approval; the approval was withdrawn in June 2023. Today it is available only through compounding by licensed-provider prescription. Vita Bella pairs oxandrolone with testosterone, and testosterone carries its own cardiovascular considerations worth understanding before starting any protocol. For background on testosterone's effect on blood pressure and the reasoning behind combining both compounds, the article on oxandrolone and testosterone therapy explains the protocol rationale in full.

Readers interested in supervised short-term oxandrolone can learn about provider-supervised recovery at Vita Bella and member wholesale pricing on medications.

Is anavar bad for your heart? Lipid shifts and possible anavar blood pressure effects are real cardiovascular considerations. They may occur, and providers can follow them with baseline and follow-up lipid labs, along with home or in-clinic blood pressure readings, during treatment. When oxandrolone is paired with testosterone, providers also account for cardiovascular health across both compounds as part of a broader provider-guided hormone protocol.

Alert symptoms warranting immediate provider contact or emergency care include chest pain, shortness of breath, and significant swelling in the legs or ankles.